See All Slides - tctmd.com

Slides

Presentation TCT 2013

BVS in Long Lesions: How to Overlap (With Case Examples)

Presenter: Robert Welsh

October 30, 2013

Presentation TCT 2013

Motion: All Patients with Multivessel Disease and Impaired Left Ventricular Function Should Undergo Revascularization - Against: Revascularization Should be Reserved for Patient...

Presenter: Rita Redberg

October 30, 2013

Presentation TCT 2013

Carotid Stenting Randomized Trials Redux: ACST2, SPACE 2, and CREST2

Presenter: Alison Halliday

October 30, 2013

Presentation TCT 2013

MitraClip Patient Selection for FMR II. Identifying Appropriate Patients

Presenter: Anita Asgar

October 30, 2013

Presentation TCT 2013

IVUS in Patients with Acute Coronary Syndromes

Presenter: Hector Garcia-Garcia

October 30, 2013

Presentation TCT 2013

Medical, Transcatheter and Surgical Therapies for Ischemic MR

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards

Presenter: Roxana Mehran

October 30, 2013

Presentation TCT 2013

Ventricular Septal Closure Devices: Congenital and Acquired

Presenter: Itzhak Kronzon

October 30, 2013

Presentation TCT 2013

Antiplatelet Agent Conundrums: Potency, Resistance, Duration, and Single/Dual/Triple Therapy

Presenter: Matthew Price

October 30, 2013

Presentation TCT 2013

“Most Advanced” CTO Crossing Strategy in the New Guidewire Era

Presenter: Osamu Katoh

October 30, 2013

Advertisement

Slides

BVS in Long Lesions: How to Overlap (With Case Examples)

Motion: All Patients with Multivessel Disease and Impaired Left Ventricular Function Should Undergo Revascularization - Against: Revascularization Should be Reserved for Patient...

Carotid Stenting Randomized Trials Redux: ACST2, SPACE 2, and CREST2

MitraClip Patient Selection for FMR II. Identifying Appropriate Patients

IVUS in Patients with Acute Coronary Syndromes

Medical, Transcatheter and Surgical Therapies for Ischemic MR

The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards

Ventricular Septal Closure Devices: Congenital and Acquired

Antiplatelet Agent Conundrums: Potency, Resistance, Duration, and Single/Dual/Triple Therapy

“Most Advanced” CTO Crossing Strategy in the New Guidewire Era

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content